Lumida
/ENFN
⌘K
Enfusion Inc

Enfusion Inc

ENFN
$10.76USD-0.37%-0.04 today

MARKET CAP

1.4B

P/E (TTM)

358.7x

FWD P/E

DAY RANGE

$11 – $11

52W RANGE

$8
$12
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024TREND
Sales, Adj.$111.7M$150.3M$174.5M$201.6M
YoY %+34.6%+16.1%+15.5%
P / Sales
EV / Sales
Gross Profit, Adj.$79.9M$103.2M$116.9M$136.7M
YoY %+29.3%+13.2%+17.0%
Margin %71.5%68.7%67.0%67.8%
EV / Gross Profit
EBITDA, Adj.$-271.9M$-5.6M$21.9M$17.9M
YoY %+97.9%+490.3%-18.4%
Margin %-243.4%-3.7%12.6%8.9%
EV / EBITDA
EBIT$-275.9M$-12.0M$11.9M$6.2M
YoY %+95.7%+199.9%-48.5%
Margin %-247.0%-8.0%6.8%3.1%
EV / EBIT
Net Income$-187.8M$-7.7M$6.0M$2.8M
YoY %+95.9%+178.7%-53.1%
Net Margin-168.1%-5.1%3.5%1.4%
EPS (GAAP)-$2.26-$0.10$0.07$0.03
YoY %+95.6%+170.0%-57.1%